Login

Register

Login

Register

Johnson & Johnson (JNJ) Drops After Vaccine Results, Watch This Level

This morning, leading pharmaceutical and health care products company, Johnson & Johnson (JNJ), is falling lower by $6.40 a share to $162.75 a share. The decline comes after the heath-care giant reported that their COVID-19 vaccine candidate was 66% effective overall in preventing moderate to severe COVID-19. In all fairness, Johnson & Johnson stock has been serging recently to new all time highs. So this looks like a buy the rumor sell the news event.

Traders should now watch for solid daily chart support around the $154.00 level. This level is where the 50-day moving average is currently located. It is also a level where the stock broke out in early January. Often, prior breakout levels are very good support when they are backtested.

Get EVERY trade Nick is taking with his members right here…

Get all of Nick’s OPTIONS Swing Trades here    <<>>    Get all of Nick’s STOCK Swing Trades here